Cell and gene therapies are among the fastest-growing areas of therapeutics, poised to revolutionize the treatment landscape and bring hope to those facing severe and untreatable diseases. However, experts stress that tackling key challenges is essential for the long-term success of CGT commercialization.
At the Cell & Gene Meeting on the Mesa in Arizona, experts shared the current challenges in CGT commercialization and outlined strategies for success, including:
- Challenges in clinical development
- The impact of automation and AI on manufacturing
- The necessity of early and ongoing regulatory engagement
- Financial viability and payer reimbursement
- Collaboration with academia, biotech and pharma to enhance efficiency
Download the Roundtable report: Keeping Pace with CGT Innovation: Clinical, Regulatory & Commercial Considerations
